Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer

NCT06328361 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-09-02

No results posted yet for this study

Summary

The goal of this one-arm clinical trial is to implement and study the oncological outcomes of nonoperative management of rectal cancer having complete clinical response to neoadjuvant therapy. The main questions to answer are

* if the oncological results of nonoperative management after Nordic practice in chemoradiotherapy indications differ from experiences elsewhere
* what is the organ preservation rate
* what is the local regrowth rate

Conditions

Interventions

PROCEDURE

Nonoperative surveillance

Clinical and imaging surveillance with digital rectal examination and/or endoscopy, rectal MRI and body CT

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Turku University Hospital

    collaborator OTHER_GOV
  • Kuopio University Hospital

    collaborator OTHER
  • Oulu University Hospital

    collaborator OTHER
  • Jyväskylä Central Hospital

    collaborator OTHER
  • Seinajoki Central Hospital

    collaborator OTHER
  • Satakunta Central Hospital

    collaborator OTHER
  • North Karelia Central Hospital

    collaborator OTHER
  • Tartu University Hospital

    collaborator OTHER
  • East Tallinn Central Hospital

    collaborator OTHER
  • West Tallinn Central Hospital

    collaborator UNKNOWN
  • North Estonia Medical Centre

    collaborator OTHER
  • Vaasa Central Hospital, Vaasa, Finland

    collaborator OTHER
  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Toni T Seppälä, MD, PhD · Tampere University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2028-12-31
Completion
2032-12-31

Countries

  • Estonia
  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06328361 on ClinicalTrials.gov